Budesonide 21-phosphate salts and pharmaceutical compositions containing the same
Номер патента: EP4126898A1
Опубликовано: 08-02-2023
Автор(ы): Antonio Petti, Beatrice Severino, Elisa Magli, Elisa PERISSUTTI, Ferdinando Fiorino, Fiorentina ROVIEZZO, Francesco FRECENTESE, Giuseppe Caliendo, Giuseppe Cirino, Marcelo Nicolas MUSCARA', Vincenzo Santagada
Принадлежит: Genetic SpA
Опубликовано: 08-02-2023
Автор(ы): Antonio Petti, Beatrice Severino, Elisa Magli, Elisa PERISSUTTI, Ferdinando Fiorino, Fiorentina ROVIEZZO, Francesco FRECENTESE, Giuseppe Caliendo, Giuseppe Cirino, Marcelo Nicolas MUSCARA', Vincenzo Santagada
Принадлежит: Genetic SpA
Реферат: The present invention relates to salts of budesonide 21-phosphate with β2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.
Ceramide derivatives having agonistic effects on epidermal cannabinoid receptors, and pharmaceutical or cosmetic composition containing same
Номер патента: US09796665B2. Автор: Bu-Mahn Park,Bong-Woo Kim,Se Kyoo Jeong,Jeong Eun Jeon. Владелец: Neopharm Co Ltd. Дата публикации: 2017-10-24.